Ibrutinib in Relapse or Refractory Primary CNS and Vitreo-Retinal Lymphoma. Results of the Primary End-Point of the I Loc Phase Ii Study From the Lysa and the French Loc Network.

Hematological Oncology - United Kingdom
doi 10.1002/hon.2437_59
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R Pvrl): A Simple, Cheap, Effective and Well Tolerated Treatment. Result of the Largest Study on R/R Pvrl, From the Loc Network

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The 5-Year Follow-Up Results of the C5r Protocol With Rituximab and Intrathecal Liposomal Cytarabine for Primary CNS Lymphoma: A Prospective Phase 2 Study of the Lysa

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Early Relapses in Primary CNS Lymphoma After Response to Polychemotherapy Without Intraventricular Treatment: Results of a Phase II Study

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2008English

Primary Analysis Results of the Single-Arm Phase Ii Study of Mor208 Plus Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (L-Mind)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Characteristics and Natural History of Primary Vitreoretinal Lymphoma (PVL) Compared to the Primary Lymphoma of the CNS (PCNSL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

LOC Syndrome

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy